Medical device and MedTech insights, news, tips and more

CardiaCare Names Ken Nelson Chairman of its Board of Directors

May 12, 2023

image-4

CardiaCare, a clinical stage digital therapeutic company developing the world’s first non-invasive, neuromodulation wearable for atrial fibrillation treatment, announced today that Ken Nelson has been appointed Chairman of the Board. Mr. Nelson is a 20-year digital health, medical device, and remote patient monitoring executive with a stellar track record of building successful sales, marketing  and commercialization teams at Fortune 500 companies as well as startups.

“We are privileged and excited to welcome Ken Nelson to CardiaCare as Chairman of the Board of Directors,” said Ofer Halbreich, CEO of CardiaCare. “Ken brings a wealth of market development, commercialization and sales experience in the cardiac monitoring and cardiac rhythm management space. Ken joins CardiaCare as the company ramps up multiple clinical trials of our revolutionary wearable for atrial fibrillation treatment. Ken’s prior experience and success scaling cardiac device companies will be invaluable to us as we create global awareness of CardiaCare’s disruptive innovation and build out the infrastructure towards successful commercialization of our technology.”

Mr. Nelson spent just under 10 years in sales and commercial operations leadership roles at Boston Scientific (formerly Guidant) in the Cardiac Rhythm Management division. Then, over the past 12 years, he has led commercial sales and marketing efforts and has launched disruptive wearable technologies in cardiac digital health and remote patient monitoring. He played a significant role in building the teams, cultures, and infrastructures for what have become three of the top four market share players in cardiac digital health and remote patient monitoring (iRhythm; Biotelemetry, acquired by Philips; Bardy Diagnostics, acquired by HillRom). Most recently, he served as Head of Digital Health, Diagnostics, and Monitoring at BIOTRONIK, a global leader in the treatment of cardiac and vascular disease.

Amos Ziv, founder and CSO, of CardiaCare adds, “CardiaCare is committed to disrupting the atrial fibrillation treatment paradigm, enabling effective, non-invasive, side-effect free therapy for AFib with our first of its kind home-care wearable technology. We’ve made important strides in the development of our technology, including the recent licensing and distribution agreement with Dr. Reddy’s Laboratories in India and multiple clinical trials now underway. We look forward to Ken’s leadership contribution to continue building on this momentum.”

“I am pleased to join CardiaCare and look forward to working with the management team and the Board, to commercialize the first ever wearable device for closed loop, personalized, atrial fibrillation treatment, powered by artificial intelligence, that can both detect and treat atrial fibrillation non-invasively,” said Ken Nelson, Chairman of the Board, CardiaCare. “I’m impressed with the company’s revolutionary technology and the successful engagement with key opinion leaders including Mount Sinai electrophysiologist Dr. Vivek Reddy. I believe CardiaCare’s innovative solution is poised to advance patient care for the treatment of atrial fibrillation.”

About CardiaCare

CardiaCare is a clinical stage digital therapeutic company developing the world’s first closed-loop neuromodulation wearable for non-invasive, AI-based arrythmia care. CardiaCare was a Medtech Innovator 2022 cohort member. For more information, visit our website and follow us on LinkedIn.

See Full Press Release at the Source: CardiaCare Names Ken Nelson Chairman of its Board of Directors


Press Release by: CardiaCare


Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.